妊娠期糖尿病与不良妊娠结局:系统综述与荟萃分析
该研究为系统综述与荟萃分析,纳入1990年1月1日至2021年11月1日发表的156项研究、共7 506 061次妊娠,评估妊娠期糖尿病与不良妊娠结局的关联。按是否使用胰岛素分亚组,在调整混杂因素后,未使用胰岛素亚组中妊娠期糖尿病与剖宫产(OR 1.16,95%CI 1.03-1.32)、早产(1.51,1.26-1.80)、1分钟Apgar评分低(1.43,1.01-2.03)、巨大儿(1.70,1.23-2.36)及大于胎龄儿(1.57,1.25-1.97)风险升高相关;使用胰岛素亚组中与大于胎龄儿(1.61,1.09-2.37)、新生儿呼吸窘迫综合征(1.57,1.19-2.08)、新生儿黄疸(1.28,1.02-1.62)及新生儿重症监护室入住(2.29,1.59-3.31)风险升高相关。器械助产、肩难产、产后出血、死产、新生儿死亡、5分钟Apgar评分低、低出生体重及小于胎龄儿未见明确差异。
要点
- 未使用胰岛素的妊娠期糖尿病孕妇,调整混杂后剖宫产风险升高(OR 1.16,95%CI 1.03-1.32)。
- 未使用胰岛素者早产(OR 1.51,95%CI 1.26-1.80)和巨大儿(OR 1.70,95%CI 1.23-2.36)风险升高。
- 使用胰岛素者新生儿重症监护室入住风险升高(OR 2.29,95%CI 1.59-3.31)。
- 使用胰岛素者大于胎龄儿(OR 1.61,95%CI 1.09-2.37)和新生儿呼吸窘迫综合征(OR 1.57,95%CI 1.19-2.08)风险升高。
- 国家发达状态、是否调整体重指数及筛查方法对多个不良结局的异质性有显著贡献。
适用人群与场景
- 妊娠期糖尿病孕妇,来自队列研究及试验对照臂,报告妊娠并发症。
- 研究按胰岛素使用情况分为三组:未使用胰岛素、使用胰岛素(不同比例患者接受胰岛素治疗)、未报告胰岛素使用。
研究设计与关键结果
- 纳入156项研究,共7 506 061次妊娠;50项(32.1%)研究偏倚风险为低或中等。
- 未使用胰岛素亚组,调整混杂后,妊娠期糖尿病与剖宫产(OR 1.16,95%CI 1.03-1.32)、早产(OR 1.51,95%CI 1.26-1.80)、1分钟Apgar评分低(OR 1.43,95%CI 1.01-2.03)、巨大儿(OR 1.70,95%CI 1.23-2.36)、大于胎龄儿(OR 1.57,95%CI 1.25-1.97)风险升高相关。
- 使用胰岛素亚组,调整混杂后,妊娠期糖尿病与大于胎龄儿(OR 1.61,95%CI 1.09-2.37)、新生儿呼吸窘迫综合征(OR 1.57,95%CI 1.19-2.08)、新生儿黄疸(OR 1.28,95%CI 1.02-1.62)、新生儿重症监护室入住(OR 2.29,95%CI 1.59-3.31)风险升高相关。
- 调整混杂后,器械助产、肩难产、产后出血、死产、新生儿死亡、5分钟Apgar评分低、低出生体重、小于胎龄儿的比值比未见明确差异证据。
- 国家发达状态、是否调整体重指数、筛查方法对多个不良妊娠结局的研究间异质性有显著贡献。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析,纳入队列研究及试验对照臂。
- 50项(32.1%)研究偏倚风险为低或中等。
- 局限:未来原始研究应常规考虑调整更完整的预后因素集。
对床旁实践的改变
- 作者认为,调整混杂因素后妊娠期糖尿病与妊娠并发症显著相关,该发现有助于更全面理解妊娠期糖尿病相关的不良妊娠结局。
- 作者建议,未来原始研究应常规考虑调整更完整的预后因素集。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the association between gestational diabetes mellitus and adverse outcomes of pregnancy after adjustment for at least minimal confounding factors.
DESIGN: Systematic review and meta-analysis.
DATA SOURCES: Web of Science, PubMed, Medline, and Cochrane Database of Systematic Reviews, from 1 January 1990 to 1 November 2021.
REVIEW METHODS: Cohort studies and control arms of trials reporting complications of pregnancy in women with gestational diabetes mellitus were eligible for inclusion. Based on the use of insulin, studies were divided into three subgroups: no insulin use (patients never used insulin during the course of the disease), insulin use (different proportions of patients were treated with insulin), and insulin use not reported. Subgroup analyses were performed based on the status of the country (developed or developing), quality of the study, diagnostic criteria, and screening method. Meta-regression models were applied based on the proportion of patients who had received insulin.
RESULTS: 156 studies with 7 506 061 pregnancies were included, and 50 (32.1%) showed a low or medium risk of bias. In studies with no insulin use, when adjusted for confounders, women with gestational diabetes mellitus had increased odds of caesarean section (odds ratio 1.16, 95% confidence interval 1.03 to 1.32), preterm delivery (1.51, 1.26 to 1.80), low one minute Apgar score (1.43, 1.01 to 2.03), macrosomia (1.70, 1.23 to 2.36), and infant born large for gestational age (1.57, 1.25 to 1.97). In studies with insulin use, when adjusted for confounders, the odds of having an infant large for gestational age (odds ratio 1.61, 1.09 to 2.37), or with respiratory distress syndrome (1.57, 1.19 to 2.08) or neonatal jaundice (1.28, 1.02 to 1.62), or requiring admission to the neonatal intensive care unit (2.29, 1.59 to 3.31), were higher in women with gestational diabetes mellitus than in those without diabetes. No clear evidence was found for differences in the odds of instrumental delivery, shoulder dystocia, postpartum haemorrhage, stillbirth, neonatal death, low five minute Apgar score, low birth weight, and small for gestational age between women with and without gestational diabetes mellitus after adjusting for confounders. Country status, adjustment for body mass index, and screening methods significantly contributed to heterogeneity between studies for several adverse outcomes of pregnancy.
CONCLUSIONS: When adjusted for confounders, gestational diabetes mellitus was significantly associated with pregnancy complications. The findings contribute to a more comprehensive understanding of the adverse outcomes of pregnancy related to gestational diabetes mellitus. Future primary studies should routinely consider adjusting for a more complete set of prognostic factors.
REVIEW REGISTRATION: PROSPERO CRD42021265837.
参考来源
- Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022. PMID: 35613728. doi:10.1136/bmj-2021-067946
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。